Literature DB >> 14578184

The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI/III but also by efficient clearance and endocytosis of immune complexes.

Peter van Lent1, Karin C Nabbe, Peter Boross, Arjen B Blom, Johannes Roth, Astrid Holthuysen, Annet Sloetjes, Sjef Verbeek, Wim van den Berg.   

Abstract

Studies of FcgammaRII-/- mice identified the inhibitory function of this receptor in joint inflammation and cartilage destruction induced with immune complexes (ICs). To extend our insight in the role of FcgammaRII in arthritis, we explored the role of FcgammaRII in the absence of activating receptors I and III using FcgammaRI/III-/- as well as FcgammaRI/II/III-/- mice. When antigen-induced arthritis (AIA) was elicited, which is a mixture of T cell and IC-driven inflammation, arthritis was almost absent at day 7 in FcgammaRI/III-/- mice. Remarkably, in FcgammaRI/II/III-/- mice, this model induced a tremendously increased arthritis as compared to wild-type controls. This implies that FcgammaRII regulates joint inflammation also in the absence of activating FcgammaRI and III. To confirm the IC specificity of this finding, similar studies were done with ICs or zymosan as arthritogenic stimuli. Strongly elevated inflammation was found in FcgammaRI/II/III-/- mice with IC but not with zymosan. Clearance studies identified accumulation of IgG in the knee joint in the absence of FcgammaRII. Moreover, macrophages expressing only FcgammaRII showed prominent endocytosis of preformed soluble ICs not different from controls. In total absence of FcgammaR (FcgammaRI/II/III-/-), macrophages completely failed to endocytose ICs. Although joint inflammation was much higher in AIA arthritic knee joints of FcgammaRI/II/III-/- and the inflammatory cells still expressed an inflammatory phenotype, severe cartilage destruction (MMP-mediated neoepitopes in the matrix and chondrocyte death) was completely prevented in contrast to the marked destruction which was observed in the wild-type. Our study indicates that FcgammaRII reduces joint inflammation in the absence of activating FcgammaR by promoting endocytosis and clearance of ICs from the joint. Infiltrating cells, which fail to express activating FcgammaR although they still become stimulated are no longer capable of inducing severe cartilage destruction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578184      PMCID: PMC1892415          DOI: 10.1016/s0002-9440(10)63543-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Authors:  Nelli Shushakova; Julia Skokowa; Jurriaan Schulman; Ulrich Baumann; Jörg Zwirner; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis.

Authors:  Tetsuya Tomita; Takanobu Nakase; Motoharu Kaneko; Kenrin Shi; Koichiro Takahi; Takahiro Ochi; Hideki Yoshikawa
Journal:  Arthritis Rheum       Date:  2002-02

3.  FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

Authors:  A Ioan-Facsinay; S J de Kimpe; S M M Hellwig; P L van Lent; F M A Hofhuis; H H van Ojik; C Sedlik; S A da Silveira; J Gerber; Y F de Jong; R Roozendaal; L A Aarden; W B van den Berg; T Saito; D Mosser; S Amigorena; S Izui; G J B van Ommen; M van Vugt; J G J van de Winkel; J S Verbeek
Journal:  Immunity       Date:  2002-03       Impact factor: 31.745

4.  Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis.

Authors:  J B van Meurs; P L van Lent; A E Holthuysen; I I Singer; E K Bayne; W B van den Berg
Journal:  Arthritis Rheum       Date:  1999-06

5.  Arthritis critically dependent on innate immune system players.

Authors:  Hong Ji; Koichiro Ohmura; Umar Mahmood; David M Lee; Frans M A Hofhuis; Susan A Boackle; Kazue Takahashi; V Michael Holers; Mark Walport; Craig Gerard; Alan Ezekowitz; Michael C Carroll; Michael Brenner; Ralph Weissleder; J Sjef Verbeek; Veronique Duchatelle; Claude Degott; Christophe Benoist; Diane Mathis
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

6.  FcgammaRIIB-mediated inhibition of T-cell receptor signal transduction involves the phosphorylation of SH2-containing inositol 5-phosphatase (SHIP), dephosphorylation of the linker of activated T-cells (LAT) and inhibition of calcium mobilization.

Authors:  W A Jensen; S Marschner; V L Ott; J C Cambier
Journal:  Biochem Soc Trans       Date:  2001-11       Impact factor: 5.407

Review 7.  Complement's participation in acquired immunity.

Authors:  Claus Henrik Nielsen; Robert Graham Quinton Leslie
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

8.  Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway.

Authors:  Sang-Oh Yoon; Soo-Jin Park; Sun Young Yoon; Chang-Hyun Yun; An-Sik Chung
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

9.  Coordinate expression of activating Fc gamma receptors I and III and inhibiting Fc gamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis.

Authors:  K C A M Nabbe; A B Blom; A E M Holthuysen; P Boross; J Roth; S Verbeek; P L E M van Lent; W B van den Berg
Journal:  Arthritis Rheum       Date:  2003-01

10.  Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody.

Authors:  Samareh Azeredo da Silveira; Shuichi Kikuchi; Liliane Fossati-Jimack; Thomas Moll; Takashi Saito; J Sjef Verbeek; Marina Botto; Mark J Walport; Michael Carroll; Shozo Izui
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

View more
  15 in total

Review 1.  Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis.

Authors:  T R D J Radstake; A W T van Lieshout; P L C M van Riel; W B van den Berg; G J Adema
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

Review 2.  The danger from within: alarmins in arthritis.

Authors:  Meriam Nefla; Dirk Holzinger; Francis Berenbaum; Claire Jacques
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

Review 3.  The complex role of Fcgamma receptors in the pathology of arthritis.

Authors:  Peter Boross; J Sjef Verbeek
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

4.  Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases.

Authors:  Ning Li; Minglang Zhao; Julio Hilario-Vargas; Phillip Prisayanh; Simon Warren; Luis A Diaz; Derry C Roopenian; Zhi Liu
Journal:  J Clin Invest       Date:  2005-11-10       Impact factor: 14.808

5.  A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.

Authors:  Sarah Weber; Haijun Tian; Nico van Rooijen; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2012-01-30       Impact factor: 3.441

Review 6.  FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

Authors:  Kenneth G C Smith; Menna R Clatworthy
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

7.  p21Cip1 is required for the development of monocytes and their response to serum transfer-induced arthritis.

Authors:  John C Scatizzi; Jack Hutcheson; Emily Bickel; James M Woods; Karolina Klosowska; Terry L Moore; G Kenneth Haines; Harris Perlman
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  IgG is elevated in obese white adipose tissue but does not induce glucose intolerance via Fcγ-receptor or complement.

Authors:  A D van Dam; L van Beek; A C M Pronk; S M van den Berg; J Van den Bossche; M P J de Winther; F Koning; C van Kooten; P C N Rensen; M R Boon; J S Verbeek; K Willems van Dijk; V van Harmelen
Journal:  Int J Obes (Lond)       Date:  2017-08-30       Impact factor: 5.095

9.  Fc Gamma Receptors as Regulators of Bone Destruction in Inflammatory Arthritis.

Authors:  Yuyue Zuo; Guo-Min Deng
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

10.  Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation.

Authors:  Wouter Hofkens; Rik Schelbergen; Gert Storm; Wim B van den Berg; Peter L van Lent
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.